Cargando…
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)
INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776256/ https://www.ncbi.nlm.nih.gov/pubmed/24037688 http://dx.doi.org/10.1007/s15010-013-0504-1 |
_version_ | 1782477461483683840 |
---|---|
author | Thoden, J. Potthoff, A. Bogner, J. R. Brockmeyer, N. H. Esser, S. Grabmeier-Pfistershammer, K. Haas, B. Hahn, K. Härter, G. Hartmann, M. Herzmann, C. Hutterer, J. Jordan, A. R. Lange, C. Mauss, S. Meyer-Olson, D. Mosthaf, F. Oette, M. Reuter, S. Rieger, A. Rosenkranz, T. Ruhnke, M. Schaaf, B. Schwarze, S. Stellbrink, H. J. Stocker, H. Stoehr, A. Stoll, M. Träder, C. Vogel, M. Wagner, D. Wyen, C. Hoffmann, C. |
author_facet | Thoden, J. Potthoff, A. Bogner, J. R. Brockmeyer, N. H. Esser, S. Grabmeier-Pfistershammer, K. Haas, B. Hahn, K. Härter, G. Hartmann, M. Herzmann, C. Hutterer, J. Jordan, A. R. Lange, C. Mauss, S. Meyer-Olson, D. Mosthaf, F. Oette, M. Reuter, S. Rieger, A. Rosenkranz, T. Ruhnke, M. Schaaf, B. Schwarze, S. Stellbrink, H. J. Stocker, H. Stoehr, A. Stoll, M. Träder, C. Vogel, M. Wagner, D. Wyen, C. Hoffmann, C. |
author_sort | Thoden, J. |
collection | PubMed |
description | INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A structured Medline research was performed for 12 diseases, namely Immune reconstitution inflammatory syndrome, Pneumocystis jiroveci pneumonia, cerebral toxoplasmosis, cytomegalovirus manifestations, candidiasis, herpes simplex virus infections, varizella zoster virus infections, progressive multifocal leucencephalopathy, cryptosporidiosis, cryptococcosis, nontuberculosis mycobacteria infections and tuberculosis. Due to the lack of evidence by randomized controlled trials, part of the guidelines reflects expert opinions. The German version was accepted by the German and Austrian AIDS Societies and was previously published by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF; German Association of the Scientific Medical Societies). CONCLUSION: The review presented here is a translation of a short version of the German–Austrian Guidelines of opportunistic infections in HIV patients. These guidelines are well-accepted in a clinical setting in both Germany and Austria. They lead to a similar treatment of a heterogeneous group of patients in these countries. |
format | Online Article Text |
id | pubmed-3776256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-37762562013-09-20 Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) Thoden, J. Potthoff, A. Bogner, J. R. Brockmeyer, N. H. Esser, S. Grabmeier-Pfistershammer, K. Haas, B. Hahn, K. Härter, G. Hartmann, M. Herzmann, C. Hutterer, J. Jordan, A. R. Lange, C. Mauss, S. Meyer-Olson, D. Mosthaf, F. Oette, M. Reuter, S. Rieger, A. Rosenkranz, T. Ruhnke, M. Schaaf, B. Schwarze, S. Stellbrink, H. J. Stocker, H. Stoehr, A. Stoll, M. Träder, C. Vogel, M. Wagner, D. Wyen, C. Hoffmann, C. Infection Guideline INTRODUCTION: There was a growing need for practical guidelines for the most common OIs in Germany and Austria under consideration of the local epidemiological conditions. MATERIALS AND METHODS: The German and Austrian AIDS societies developed these guidelines between March 2010 and November 2011. A structured Medline research was performed for 12 diseases, namely Immune reconstitution inflammatory syndrome, Pneumocystis jiroveci pneumonia, cerebral toxoplasmosis, cytomegalovirus manifestations, candidiasis, herpes simplex virus infections, varizella zoster virus infections, progressive multifocal leucencephalopathy, cryptosporidiosis, cryptococcosis, nontuberculosis mycobacteria infections and tuberculosis. Due to the lack of evidence by randomized controlled trials, part of the guidelines reflects expert opinions. The German version was accepted by the German and Austrian AIDS Societies and was previously published by the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF; German Association of the Scientific Medical Societies). CONCLUSION: The review presented here is a translation of a short version of the German–Austrian Guidelines of opportunistic infections in HIV patients. These guidelines are well-accepted in a clinical setting in both Germany and Austria. They lead to a similar treatment of a heterogeneous group of patients in these countries. Springer Berlin Heidelberg 2013-09-14 2013 /pmc/articles/PMC3776256/ /pubmed/24037688 http://dx.doi.org/10.1007/s15010-013-0504-1 Text en © The Author(s) 2013 Open AccessThis article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited. |
spellingShingle | Guideline Thoden, J. Potthoff, A. Bogner, J. R. Brockmeyer, N. H. Esser, S. Grabmeier-Pfistershammer, K. Haas, B. Hahn, K. Härter, G. Hartmann, M. Herzmann, C. Hutterer, J. Jordan, A. R. Lange, C. Mauss, S. Meyer-Olson, D. Mosthaf, F. Oette, M. Reuter, S. Rieger, A. Rosenkranz, T. Ruhnke, M. Schaaf, B. Schwarze, S. Stellbrink, H. J. Stocker, H. Stoehr, A. Stoll, M. Träder, C. Vogel, M. Wagner, D. Wyen, C. Hoffmann, C. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title_full | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title_fullStr | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title_full_unstemmed | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title_short | Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066) |
title_sort | therapy and prophylaxis of opportunistic infections in hiv-infected patients: a guideline by the german and austrian aids societies (daig/öag) (awmf 055/066) |
topic | Guideline |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776256/ https://www.ncbi.nlm.nih.gov/pubmed/24037688 http://dx.doi.org/10.1007/s15010-013-0504-1 |
work_keys_str_mv | AT thodenj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT potthoffa therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT bognerjr therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT brockmeyernh therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT essers therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT grabmeierpfistershammerk therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT haasb therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT hahnk therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT harterg therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT hartmannm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT herzmannc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT huttererj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT jordanar therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT langec therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT mausss therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT meyerolsond therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT mosthaff therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT oettem therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT reuters therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT riegera therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT rosenkranzt therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT ruhnkem therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT schaafb therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT schwarzes therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT stellbrinkhj therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT stockerh therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT stoehra therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT stollm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT traderc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT vogelm therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT wagnerd therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT wyenc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 AT hoffmannc therapyandprophylaxisofopportunisticinfectionsinhivinfectedpatientsaguidelinebythegermanandaustrianaidssocietiesdaigoagawmf055066 |